Safety and Efficacy of XP200 Radiofrequency Treatment of Wrinkles
NCT ID: NCT01795417
Last Updated: 2013-08-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2012-08-31
2013-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
XP200 device RF treatments
Every subject in the study will undergo 4 treatments and will be followed up for 6 months with photoraphic 3 evaluations: before treatment, 3 and 6 months follow-up. Photographs will be scored on a Fitzpatrick scale by 3 blinded evaluators.
RF XP200
Four weekly non-invasive periorbital wrinkles treatment with RF XP200 device
XP200 RF device
4 RF treatments of periorbital region on one side of the face
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
RF XP200
Four weekly non-invasive periorbital wrinkles treatment with RF XP200 device
XP200 RF device
4 RF treatments of periorbital region on one side of the face
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* periorbital wrinkles
35 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
BTL Industries Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Georgi Petkov
Role: STUDY_DIRECTOR
BTL Industries Ltd.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
XP200 3.25 MHZ RF
Identifier Type: -
Identifier Source: org_study_id